British Columbia Investment Management’s Legend Biotech LEGN Stock Holding History

British Columbia Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$517K	Hold	28,600	–	–	﹤0.01%	689
2025 Q4	$622K	Hold	28,600	–	–	﹤0.01%	687
2025 Q3	$933K	Buy	28,600 +3,600	+14%	+$133K	0.01%	664
2025 Q2	$887K	Sell	25,000 -3,800	-13%	-$123K	0.01%	660
2025 Q1	$977K	Hold	28,800	–	–	0.01%	682
2024 Q4	$937K	Hold	28,800	–	–	0.01%	697
2024 Q3	$1.4M	Hold	28,800	–	–	0.01%	670
2024 Q2	$1.28M	Hold	28,800	–	–	0.01%	682
2024 Q1	$1.62M	Hold	28,800	–	–	0.01%	614
2023 Q4	$1.73M	Buy	28,800 +5,200	+22%	+$330K	0.01%	577
2023 Q3	$1.59M	Buy	23,600 +500	+2%	+$34.7K	0.02%	492
2023 Q2	$1.59M	Sell	23,100 -700	-3%	-$45.7K	0.01%	514
2023 Q1	$1.15M	Buy	23,800 +4,000	+20%	+$196K	0.01%	605
2022 Q4	$988K	Hold	19,800	–	–	0.01%	628
2022 Q3	$808K	Buy	19,800 +900	+5%	+$42.2K	0.01%	694
2022 Q2	$1.04M	Hold	18,900	–	–	0.01%	689
2022 Q1	$687K	Hold	18,900	–	–	﹤0.01%	806
2021 Q4	$881K	Buy	+18,900	New	+$959K	0.01%	799

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

British Columbia Investment Management's LEGN Position: Q1 2026 in Review

British Columbia Investment Management held its Legend Biotech (LEGN) position steady in Q1 2026 at 28,600 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

British Columbia Investment Management first reported a position in LEGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.73M in Q4 2023. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

British Columbia Investment Management held 28,600 shares of Legend Biotech worth $517K as of Q1 2026.
British Columbia Investment Management left its Legend Biotech share count unchanged in Q1 2026.
Legend Biotech made up ﹤0.01% of British Columbia Investment Management's portfolio in Q1 2026, its #689 holding.
British Columbia Investment Management first reported a position in Legend Biotech in Q4 2021 and has held it in 18 quarters since.
British Columbia Investment Management's Legend Biotech position peaked at $1.73M in Q4 2023.
190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.